Splicing factors can serve as predictive targets for drug screening, as demonstrated by Wan LD et al.'s study, where SRSF6, an SR protein overexpressed in colorectal cancer, promotes tumor progression by regulating AS. This evidence concerns the gene RNPS1 and neoplasm.